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EDITORIAL
Diabetes, genes, and kidney development
Offspring born to mothers with insulin-dependent dia- therefore of note that this gene is expressed in maturing
betes mellitus have a high incidence of malformation proximal tubules [9].
including neural tube, skeletal, heart and urogenital de- In contrast to HNF1a, HNF1b appears essential for
fects, with absent kidneys or ‘renal agenesis’ being espe- early kidney organogenesis. In the rat metanephros,
cially common [1, 2]. In fact, it has been estimated that HNF1b is expressed in mesoderm cells as they are in-
congenital malformations account for 40% of all perina- duced to differentiate into epithelia, and is also found
tal deaths of diabetic offspring and the rate of birth in collecting ducts [9]. Bingham et al discovered a sponta-
defect correlates with blood glucose in the first trimester neous mutation in HNF1b in an woman diagnosed as
[1]. The offspring of diabetic animals also have a high diabetic in her second pregnancy [5]. As assessed by ultra-
incidence of embryopathy, and this can be reduced by
sound examination, she had normal-sized kidneys withinsulin treatment. Theories to explain hyperglycemia-
bilateral, small cysts up to 2 cm across together with ainduced malformations include the generation of free
mildly impaired creatinine clearance. The mutation, whichradicals [3] as well as a vasculopathy associated with
was absent in 50 normal chromosomes, was a small dele-abnormalities in platelet endothelial cell adhesion mole-
tion in exon 4 predicted to result in a protein with thecule 1 tyrosine phosphorylation [4].
first 327 amino acids of native HNF1b and an additional 29The above data clearly establish a teratogenic role for
amino acids from the shifted reading frame. The mutantglucose. However, evidence presented by Bingham and
would retain the amino-terminal dimerization domaincolleagues in this issue of Kidney International provide
and the DNA-binding region containing a POU-like ele-a new, genetic, link between diabetes mellitus and renal
malformation involving a gene coding for a transcription ment and a homeodomain: however, the majority of the
factor called hepatocyte nuclear factor (HNF) 1b (also transcriptional activation domain would be absent. Her
called vHNF1 and LFB3) [5]. HNF-1b functions as a first pregnancy had been terminated at 17 weeks follow-
homodimer or as a heterodimer with HNF 1a (also called ing a fetal diagnosis of enlarged cystic kidneys, although
HNF1 and LFB1). Both are expressed in primitive endo- she was not thought have diabetes at that time. Histology
derm, liver and digestive tract, and regulate transcription revealed an absence of normal nephrons. Instead, there
of diverse liver genes. HNF1b is required for specifica- were many cysts, some derived from glomeruli, together
tion of visceral endoderm [6]: null mutant mouse embryos with primitive tubules; this appearance is compatible
reach the blastocyst stage, start implantation and then die
with a diagnosis of ‘cystic dysplasia.’ This female fetuswith no discernable visceral or parietal endoderm.
had the same mutation as the mother, as did the childMaturity onset diabetes of the young (MODY) is an
born from her second pregnancy. This boy had a non-autosomal dominant disorder with diabetes mellitus char-
functioning multicystic dysplastic right kidney and a dys-acteristically occurring before 25 years of age. MODY
plastic left kidney with creatinine clearance of 40 mL/accounts for 1 to 2% of diabetes in the European Cauca-
min. This child did not have diabetes, although an oralsian population and is associated with impaired glucose-
glucose tolerance test had yet to be performed. Therestimulated insulin secretion. HNF1a mutations account
was no renal histology available from the mother or son.for 65% of MODY patients, whereas HNF1b mutations
There are currently three other published MODYaccount for rare MODY individuals. Patients with HNF1a
mutations have defects in renal resorption of glucose, families with HNF1b mutations and severe nondiabetic
phosphate and amino acids [7], and can also develop renal dysfunction. Two of these reports describe mutations
features of classical diabetic nephropathy associated with predicted to code for proteins with intact dimerisation
poor hyperglycemic control. Furthermore, HNF1a null domains but lacking the transactivation domain (letter;
mutant mice have a renal Fanconi syndrome [8]. It is Horikawa et al, Nat Genet 17:384–385, 1997; Nishigori
et al, Diabetes 47:1354–1355, 1998). These studies con-
firm that the mutations segregate with renal disease,
that the kidneys are sometimes cystic as assessed by
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onset of diabetes. These reports lack renal histology andÓ 2000 by the International Society of Nephrology
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hence a recent study by Lindner et al of a three genera- range of patients cared for by both Pediatric and Adult
Nephrologists.tion MODY kindred has particular importance [10].
These authors discovered a 75 base pair deletion in exon
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children was investigated with a renal biopsy, which re-
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